tiprankstipranks
Blurbs

Analysts Offer Insights on Services Companies: Rcm Technologies (RCMT), CuriosityStream (CURI) and OmniAb (OABI)

There’s a lot to be optimistic about in the Services sector as 3 analysts just weighed in on Rcm Technologies (RCMTResearch Report), CuriosityStream (CURIResearch Report) and OmniAb (OABIResearch Report) with bullish sentiments.

Rcm Technologies (RCMT)

In a report released today, Bill Sutherland from Benchmark Co. reiterated a Buy rating on Rcm Technologies, with a price target of $28.00. The company’s shares closed last Friday at $14.04.

According to TipRanks.com, Sutherland has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -8.5% and a 39.6% success rate. Sutherland covers the Healthcare sector, focusing on stocks such as Clinigence Holdings, Surgery Partners, and Assure Holdings.

Currently, the analyst consensus on Rcm Technologies is a Moderate Buy with an average price target of $23.50, implying a 71.7% upside from current levels. In a report released yesterday, B.Riley Financial also maintained a Buy rating on the stock with a $19.00 price target.

See the top stocks recommended by analysts >>

CuriosityStream (CURI)

In a report released today, Laura Martin from Needham reiterated a Buy rating on CuriosityStream, with a price target of $2.00. The company’s shares closed last Friday at $1.04, close to its 52-week low of $0.95.

According to TipRanks.com, Martin is ranked 0 out of 5 stars with an average return of -4.1% and a 40.3% success rate. Martin covers the Services sector, focusing on stocks such as Paramount Global Class B, Tremor International, and Walt Disney.

CuriosityStream has an analyst consensus of Hold, with a price target consensus of $1.58, which is a 46.3% upside from current levels. In a report released today, D.A. Davidson also reiterated a Buy rating on the stock.

OmniAb (OABI)

In a report released today, Robert Wasserman from Benchmark Co. reiterated a Buy rating on OmniAb, with a price target of $8.00. The company’s shares closed last Friday at $3.44.

According to TipRanks.com, Wasserman has 0 stars on 0-5 stars ranking scale with an average return of -6.6% and a 25.0% success rate. Wasserman covers the Healthcare sector, focusing on stocks such as Anebulo Pharmaceuticals, Emergent Biosolutions, and Champions Oncology.

Currently, the analyst consensus on OmniAb is a Strong Buy with an average price target of $9.40, representing a 176.5% upside. In a report released yesterday, H.C. Wainwright also reiterated a Buy rating on the stock with a $11.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on RCMT:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles